论文部分内容阅读
目的:探讨更昔洛韦对婴幼儿手足口病(HFMD)的临床疗效。方法;将50例HFMD患儿随机分成治疗组和对照组。治疗组加用更昔洛韦观察临床有效率。结果;临床有效率治疗组92%,对照组52%,P<0.05,差异具有显著性。结论:治疗组优于对照组。
Objective: To investigate the clinical effect of ganciclovir on infant hand-foot-mouth disease (HFMD). Methods Fifty children with HFMD were randomly divided into treatment group and control group. The treatment group plus ganciclovir observation of clinical efficiency. Results: The clinical effective rate was 92% in the treatment group and 52% in the control group, P <0.05, the difference was significant. Conclusion: The treatment group is better than the control group.